Transjugular craniotomy for the management of jugular foramen tumors with intracranial extension

To elucidate indications and outcomes with the transjugular craniotomy for resection of jugular foramen tumors with intracranial extension. The transjugular approach is a lateral craniotomy conducted through a partial petrosectomy traversing the jugular fossa combined with resection of the sigmoid s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Otology & neurotology 2004-07, Vol.25 (4), p.570-579
Hauptverfasser: Oghalai, John S, Leung, Man-Kit, Jackler, Robert K, McDermott, Michael W
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 579
container_issue 4
container_start_page 570
container_title Otology & neurotology
container_volume 25
creator Oghalai, John S
Leung, Man-Kit
Jackler, Robert K
McDermott, Michael W
description To elucidate indications and outcomes with the transjugular craniotomy for resection of jugular foramen tumors with intracranial extension. The transjugular approach is a lateral craniotomy conducted through a partial petrosectomy traversing the jugular fossa combined with resection of the sigmoid sinus and jugular bulb, which often have been occluded by disease. Retrospective review. University medical center. Twenty-eight patients with intracranial jugular foramen tumors who underwent a total of 30 surgical procedures. Pathologic findings, surgical approach, extent of tumor resection, rate of facial nerve mobilization and ear canal closure, facial and lower cranial nerve outcomes, and hearing preservation. Tumors included schwannoma (37%), meningioma (33%), glomus jugulare (23%), and chordoma (7%). The surgical approaches were tailored to maximize functional preservation, and included the transjugular (53%), translabyrinthine (17%), retrosigmoid (10%), and far lateral (7%) craniotomies. Translabyrinthine (3%) or transcondylarfar lateral (3%) approaches were occasionally used in combination with the trans-jugular approach. Most procedures were managed in a single stage (90%), but three patients with massive tumor in the neck required two stages. Microsurgical gross total and near-total tumor removal (37% each) were commonly achieved, although subtotal resections (27%) were occasionally performed. In only a minority of cases was facial nerve mobilization (7%) or ear canal closure (21%) required. If present preoperatively, Grade I facial nerve function was usually maintained (22 of 24 [92%]) and Hearing Class A or B could always be maintained (9 of 9 [100%]). As expected, new lower cranial nerve dysfunction was common (8 of 30 [27%]), although over half of the patients had complete lower nerve palsy preoperatively (16 of 30 [53%]). Most patients with jugular foramen tumors with intracranial extension can be managed with a single-stage transjugular craniotomy. Facial nerve mobilization or ear canal closure is usually not required, permitting conservation of facial function and hearing, when present preoperatively.
doi_str_mv 10.1097/00129492-200407000-00026
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66686246</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>66686246</sourcerecordid><originalsourceid>FETCH-LOGICAL-c311t-be93682cdf539e31d8e7b6a76be8e9844f332cfbc5e77ba62c6a82e10d81d8933</originalsourceid><addsrcrecordid>eNpFkEtPwzAMgHMAsTH4CygnboU82iQ9oomXNInLOIc0dbdObTOSVLB_T9gDDpZl-7MtfQhhSu4oKeU9IZSVeckyRkhOJCEkS8HEGZrSgtNMpvEEXYawSaTkhbxAE1qwnDIup-hj6c0QNuNq7IzHNhWti67f4cZ5HNeAezOYFfQwROwafALT1KQejmPvfMBfbVzjdoje7C-YDsN3hCG0brhC543pAlwf8wy9Pz0u5y_Z4u35df6wyCynNGYVlFwoZuum4CVwWiuQlTBSVKCgVHnecM5sU9kCpKyMYFYYxYCSWiW25HyGbg93t959jhCi7ttgoevMAG4MWgihBMtFAtUBtN6F4KHRW9_2xu80JfrXqD4Z1X9G9d5oWr05_hirHur_xaNO_gNaUHXL</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66686246</pqid></control><display><type>article</type><title>Transjugular craniotomy for the management of jugular foramen tumors with intracranial extension</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Oghalai, John S ; Leung, Man-Kit ; Jackler, Robert K ; McDermott, Michael W</creator><creatorcontrib>Oghalai, John S ; Leung, Man-Kit ; Jackler, Robert K ; McDermott, Michael W</creatorcontrib><description>To elucidate indications and outcomes with the transjugular craniotomy for resection of jugular foramen tumors with intracranial extension. The transjugular approach is a lateral craniotomy conducted through a partial petrosectomy traversing the jugular fossa combined with resection of the sigmoid sinus and jugular bulb, which often have been occluded by disease. Retrospective review. University medical center. Twenty-eight patients with intracranial jugular foramen tumors who underwent a total of 30 surgical procedures. Pathologic findings, surgical approach, extent of tumor resection, rate of facial nerve mobilization and ear canal closure, facial and lower cranial nerve outcomes, and hearing preservation. Tumors included schwannoma (37%), meningioma (33%), glomus jugulare (23%), and chordoma (7%). The surgical approaches were tailored to maximize functional preservation, and included the transjugular (53%), translabyrinthine (17%), retrosigmoid (10%), and far lateral (7%) craniotomies. Translabyrinthine (3%) or transcondylarfar lateral (3%) approaches were occasionally used in combination with the trans-jugular approach. Most procedures were managed in a single stage (90%), but three patients with massive tumor in the neck required two stages. Microsurgical gross total and near-total tumor removal (37% each) were commonly achieved, although subtotal resections (27%) were occasionally performed. In only a minority of cases was facial nerve mobilization (7%) or ear canal closure (21%) required. If present preoperatively, Grade I facial nerve function was usually maintained (22 of 24 [92%]) and Hearing Class A or B could always be maintained (9 of 9 [100%]). As expected, new lower cranial nerve dysfunction was common (8 of 30 [27%]), although over half of the patients had complete lower nerve palsy preoperatively (16 of 30 [53%]). Most patients with jugular foramen tumors with intracranial extension can be managed with a single-stage transjugular craniotomy. Facial nerve mobilization or ear canal closure is usually not required, permitting conservation of facial function and hearing, when present preoperatively.</description><identifier>ISSN: 1531-7129</identifier><identifier>DOI: 10.1097/00129492-200407000-00026</identifier><identifier>PMID: 15241237</identifier><language>eng</language><publisher>United States</publisher><subject>Adult ; Aged ; Child ; Chordoma - pathology ; Chordoma - surgery ; Cranial Nerve Diseases - etiology ; Craniotomy - adverse effects ; Craniotomy - methods ; Facial Nerve - physiology ; Female ; Glomus Jugulare Tumor - pathology ; Glomus Jugulare Tumor - surgery ; Hearing Loss - prevention &amp; control ; Humans ; Magnetic Resonance Imaging ; Male ; Meningeal Neoplasms - pathology ; Meningeal Neoplasms - surgery ; Meningioma - pathology ; Meningioma - surgery ; Middle Aged ; Monitoring, Intraoperative ; Neurilemmoma - pathology ; Neurilemmoma - surgery ; Retrospective Studies ; Skull Base Neoplasms - pathology ; Skull Base Neoplasms - surgery ; Treatment Outcome</subject><ispartof>Otology &amp; neurotology, 2004-07, Vol.25 (4), p.570-579</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c311t-be93682cdf539e31d8e7b6a76be8e9844f332cfbc5e77ba62c6a82e10d81d8933</citedby><cites>FETCH-LOGICAL-c311t-be93682cdf539e31d8e7b6a76be8e9844f332cfbc5e77ba62c6a82e10d81d8933</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15241237$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Oghalai, John S</creatorcontrib><creatorcontrib>Leung, Man-Kit</creatorcontrib><creatorcontrib>Jackler, Robert K</creatorcontrib><creatorcontrib>McDermott, Michael W</creatorcontrib><title>Transjugular craniotomy for the management of jugular foramen tumors with intracranial extension</title><title>Otology &amp; neurotology</title><addtitle>Otol Neurotol</addtitle><description>To elucidate indications and outcomes with the transjugular craniotomy for resection of jugular foramen tumors with intracranial extension. The transjugular approach is a lateral craniotomy conducted through a partial petrosectomy traversing the jugular fossa combined with resection of the sigmoid sinus and jugular bulb, which often have been occluded by disease. Retrospective review. University medical center. Twenty-eight patients with intracranial jugular foramen tumors who underwent a total of 30 surgical procedures. Pathologic findings, surgical approach, extent of tumor resection, rate of facial nerve mobilization and ear canal closure, facial and lower cranial nerve outcomes, and hearing preservation. Tumors included schwannoma (37%), meningioma (33%), glomus jugulare (23%), and chordoma (7%). The surgical approaches were tailored to maximize functional preservation, and included the transjugular (53%), translabyrinthine (17%), retrosigmoid (10%), and far lateral (7%) craniotomies. Translabyrinthine (3%) or transcondylarfar lateral (3%) approaches were occasionally used in combination with the trans-jugular approach. Most procedures were managed in a single stage (90%), but three patients with massive tumor in the neck required two stages. Microsurgical gross total and near-total tumor removal (37% each) were commonly achieved, although subtotal resections (27%) were occasionally performed. In only a minority of cases was facial nerve mobilization (7%) or ear canal closure (21%) required. If present preoperatively, Grade I facial nerve function was usually maintained (22 of 24 [92%]) and Hearing Class A or B could always be maintained (9 of 9 [100%]). As expected, new lower cranial nerve dysfunction was common (8 of 30 [27%]), although over half of the patients had complete lower nerve palsy preoperatively (16 of 30 [53%]). Most patients with jugular foramen tumors with intracranial extension can be managed with a single-stage transjugular craniotomy. Facial nerve mobilization or ear canal closure is usually not required, permitting conservation of facial function and hearing, when present preoperatively.</description><subject>Adult</subject><subject>Aged</subject><subject>Child</subject><subject>Chordoma - pathology</subject><subject>Chordoma - surgery</subject><subject>Cranial Nerve Diseases - etiology</subject><subject>Craniotomy - adverse effects</subject><subject>Craniotomy - methods</subject><subject>Facial Nerve - physiology</subject><subject>Female</subject><subject>Glomus Jugulare Tumor - pathology</subject><subject>Glomus Jugulare Tumor - surgery</subject><subject>Hearing Loss - prevention &amp; control</subject><subject>Humans</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>Meningeal Neoplasms - pathology</subject><subject>Meningeal Neoplasms - surgery</subject><subject>Meningioma - pathology</subject><subject>Meningioma - surgery</subject><subject>Middle Aged</subject><subject>Monitoring, Intraoperative</subject><subject>Neurilemmoma - pathology</subject><subject>Neurilemmoma - surgery</subject><subject>Retrospective Studies</subject><subject>Skull Base Neoplasms - pathology</subject><subject>Skull Base Neoplasms - surgery</subject><subject>Treatment Outcome</subject><issn>1531-7129</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkEtPwzAMgHMAsTH4CygnboU82iQ9oomXNInLOIc0dbdObTOSVLB_T9gDDpZl-7MtfQhhSu4oKeU9IZSVeckyRkhOJCEkS8HEGZrSgtNMpvEEXYawSaTkhbxAE1qwnDIup-hj6c0QNuNq7IzHNhWti67f4cZ5HNeAezOYFfQwROwafALT1KQejmPvfMBfbVzjdoje7C-YDsN3hCG0brhC543pAlwf8wy9Pz0u5y_Z4u35df6wyCynNGYVlFwoZuum4CVwWiuQlTBSVKCgVHnecM5sU9kCpKyMYFYYxYCSWiW25HyGbg93t959jhCi7ttgoevMAG4MWgihBMtFAtUBtN6F4KHRW9_2xu80JfrXqD4Z1X9G9d5oWr05_hirHur_xaNO_gNaUHXL</recordid><startdate>200407</startdate><enddate>200407</enddate><creator>Oghalai, John S</creator><creator>Leung, Man-Kit</creator><creator>Jackler, Robert K</creator><creator>McDermott, Michael W</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>8BM</scope></search><sort><creationdate>200407</creationdate><title>Transjugular craniotomy for the management of jugular foramen tumors with intracranial extension</title><author>Oghalai, John S ; Leung, Man-Kit ; Jackler, Robert K ; McDermott, Michael W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c311t-be93682cdf539e31d8e7b6a76be8e9844f332cfbc5e77ba62c6a82e10d81d8933</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Child</topic><topic>Chordoma - pathology</topic><topic>Chordoma - surgery</topic><topic>Cranial Nerve Diseases - etiology</topic><topic>Craniotomy - adverse effects</topic><topic>Craniotomy - methods</topic><topic>Facial Nerve - physiology</topic><topic>Female</topic><topic>Glomus Jugulare Tumor - pathology</topic><topic>Glomus Jugulare Tumor - surgery</topic><topic>Hearing Loss - prevention &amp; control</topic><topic>Humans</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>Meningeal Neoplasms - pathology</topic><topic>Meningeal Neoplasms - surgery</topic><topic>Meningioma - pathology</topic><topic>Meningioma - surgery</topic><topic>Middle Aged</topic><topic>Monitoring, Intraoperative</topic><topic>Neurilemmoma - pathology</topic><topic>Neurilemmoma - surgery</topic><topic>Retrospective Studies</topic><topic>Skull Base Neoplasms - pathology</topic><topic>Skull Base Neoplasms - surgery</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Oghalai, John S</creatorcontrib><creatorcontrib>Leung, Man-Kit</creatorcontrib><creatorcontrib>Jackler, Robert K</creatorcontrib><creatorcontrib>McDermott, Michael W</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>ComDisDome</collection><jtitle>Otology &amp; neurotology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Oghalai, John S</au><au>Leung, Man-Kit</au><au>Jackler, Robert K</au><au>McDermott, Michael W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transjugular craniotomy for the management of jugular foramen tumors with intracranial extension</atitle><jtitle>Otology &amp; neurotology</jtitle><addtitle>Otol Neurotol</addtitle><date>2004-07</date><risdate>2004</risdate><volume>25</volume><issue>4</issue><spage>570</spage><epage>579</epage><pages>570-579</pages><issn>1531-7129</issn><abstract>To elucidate indications and outcomes with the transjugular craniotomy for resection of jugular foramen tumors with intracranial extension. The transjugular approach is a lateral craniotomy conducted through a partial petrosectomy traversing the jugular fossa combined with resection of the sigmoid sinus and jugular bulb, which often have been occluded by disease. Retrospective review. University medical center. Twenty-eight patients with intracranial jugular foramen tumors who underwent a total of 30 surgical procedures. Pathologic findings, surgical approach, extent of tumor resection, rate of facial nerve mobilization and ear canal closure, facial and lower cranial nerve outcomes, and hearing preservation. Tumors included schwannoma (37%), meningioma (33%), glomus jugulare (23%), and chordoma (7%). The surgical approaches were tailored to maximize functional preservation, and included the transjugular (53%), translabyrinthine (17%), retrosigmoid (10%), and far lateral (7%) craniotomies. Translabyrinthine (3%) or transcondylarfar lateral (3%) approaches were occasionally used in combination with the trans-jugular approach. Most procedures were managed in a single stage (90%), but three patients with massive tumor in the neck required two stages. Microsurgical gross total and near-total tumor removal (37% each) were commonly achieved, although subtotal resections (27%) were occasionally performed. In only a minority of cases was facial nerve mobilization (7%) or ear canal closure (21%) required. If present preoperatively, Grade I facial nerve function was usually maintained (22 of 24 [92%]) and Hearing Class A or B could always be maintained (9 of 9 [100%]). As expected, new lower cranial nerve dysfunction was common (8 of 30 [27%]), although over half of the patients had complete lower nerve palsy preoperatively (16 of 30 [53%]). Most patients with jugular foramen tumors with intracranial extension can be managed with a single-stage transjugular craniotomy. Facial nerve mobilization or ear canal closure is usually not required, permitting conservation of facial function and hearing, when present preoperatively.</abstract><cop>United States</cop><pmid>15241237</pmid><doi>10.1097/00129492-200407000-00026</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1531-7129
ispartof Otology & neurotology, 2004-07, Vol.25 (4), p.570-579
issn 1531-7129
language eng
recordid cdi_proquest_miscellaneous_66686246
source MEDLINE; Journals@Ovid Complete
subjects Adult
Aged
Child
Chordoma - pathology
Chordoma - surgery
Cranial Nerve Diseases - etiology
Craniotomy - adverse effects
Craniotomy - methods
Facial Nerve - physiology
Female
Glomus Jugulare Tumor - pathology
Glomus Jugulare Tumor - surgery
Hearing Loss - prevention & control
Humans
Magnetic Resonance Imaging
Male
Meningeal Neoplasms - pathology
Meningeal Neoplasms - surgery
Meningioma - pathology
Meningioma - surgery
Middle Aged
Monitoring, Intraoperative
Neurilemmoma - pathology
Neurilemmoma - surgery
Retrospective Studies
Skull Base Neoplasms - pathology
Skull Base Neoplasms - surgery
Treatment Outcome
title Transjugular craniotomy for the management of jugular foramen tumors with intracranial extension
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T22%3A13%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transjugular%20craniotomy%20for%20the%20management%20of%20jugular%20foramen%20tumors%20with%20intracranial%20extension&rft.jtitle=Otology%20&%20neurotology&rft.au=Oghalai,%20John%20S&rft.date=2004-07&rft.volume=25&rft.issue=4&rft.spage=570&rft.epage=579&rft.pages=570-579&rft.issn=1531-7129&rft_id=info:doi/10.1097/00129492-200407000-00026&rft_dat=%3Cproquest_cross%3E66686246%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=66686246&rft_id=info:pmid/15241237&rfr_iscdi=true